Combining Radiotherapy with SOC Plus Abiraterone Improves rPFS in Patients with Low-Volume de Novo Metastatic Castration-Sensitive Prostate Cancer By Ogkologos - December 5, 2024 128 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-1 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Nivolumab and Ipilimumab to Unresectable or Advanced HCC ESMO Sarcoma and Rare Cancers Congress 2025, Lugano, Switzerland, 20-22 March New on NCI’s Websites for March 2025 MOST POPULAR Targeted Radiation Reduces Pain from Cancer Metastases in the Spine November 24, 2020 FDA Grants Accelerated Approval to Pembrolizumab for Locally Recurrent Unresectable or... November 16, 2020 ASCO Annual Meeting 2023: Trastuzumab Deruxtecan Effectively Treats HER2-Expressing Tumors and... June 5, 2023 Hiding in plain sight: How we can use immune cells to... February 9, 2023 Load more HOT NEWS Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση EMA Recommends Granting a Marketing Authorisation for Generic Abiraterone for the... Lo que deben saber las personas con cáncer de mama y... Perguntas frequentes sobre COVID-19 e câncer: respostas para pacientes e sobreviventes
